This notion was examined by Vessella and colleagues, who treated mGluR1-expressing prostate cancer cells with riluzole, which led to the induction of apoptosis and the reduced metastatic capabilities of these cells, as well as inhibition of tumor growth (Table 1) [97]. This evidence concerns the gene GRM1 and prostate carcinoma.